Insider Transactions last 24 months for Neumora Therapeutics, Inc.  -  NSDQ: NMRA

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Pinto JoshuaPresident05/21/2025AGIndirectCOM13,202$0.00$0.00152,167
Pinto JoshuaPresident05/21/2025DGDirectCOM13,202$0.00$0.0063,750
Pinto JoshuaPresident02/18/2025DSDirectCOM8,048$1.67$13,477.1876,952
Lenz Robert A.Head of R&D02/18/2025DSDirectCOM5,614$1.67$9,383.24309,092
Aurora Daljit SinghChief Strategy Officer02/18/2025DSDirectCOM8,565$1.68$14,347.2388,935
Milligan Michael LeeSee Remarks02/18/2025DSDirectCOM1,978$1.69$3,350.5322,470
Berns Paul LSee Remarks02/18/2025DSDirectCOM13,871$1.69$23,468.347,405,004
Berns Paul LDirector12/27/2024DGDirectCOM133,097$0.00$0.007,418,875
Berns Paul LDirector12/27/2024DGDirectCOM133,097$0.00$0.007,551,972
Berns Paul LDirector12/27/2024DGDirectCOM133,097$0.00$0.007,685,069
Fust Matthew KDirector10/18/2024DSDirectCOM14,049$17.03$239,319.1020,100
Fust Matthew KDirector10/18/2024AMDirectCOM7,844$2.52$19,766.8834,149
Fust Matthew KDirector10/18/2024AMDirectCOM6,205$8.79$54,541.9526,305
Fust Matthew KDirector10/17/2024DSDirectCOM7,739$17.01$131,642.7120,100
Fust Matthew KDirector10/17/2024AMDirectCOM2,156$2.52$5,433.1227,839
Fust Matthew KDirector10/17/2024AMDirectCOM1,800$8.79$15,822.0025,683
Fust Matthew KDirector10/17/2024AMDirectCOM3,783$8.32$31,474.5623,883
Lenz Robert A.Head of R&D10/10/2024DSDirectCOM8,260$15.09$124,602.93314,706
Lenz Robert A.Head of R&D10/09/2024DSDirectCOM5,563$15.01$83,507.31322,966
Lenz Robert A.Head of R&D09/18/2024DSDirectCOM10,676$12.09$129,090.99328,529
Lenz Robert A.Head of R&D09/17/2024DSDirectCOM30,788$11.81$363,735.59339,205
Lenz Robert A.Head of R&D09/12/2024DSDirectCOM32,948$11.43$376,664.83369,993
Pinto JoshuaChief Financial Officer08/27/2024DSIndirectCOM15,693$11.39$178,806.04138,965
Pinto JoshuaChief Financial Officer08/26/2024DSIndirectCOM31,642$11.78$372,587.71154,658
Pinto JoshuaChief Financial Officer08/23/2024DSIndirectCOM24,169$11.59$280,005.12186,300
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel